Awards
| Award From | Category | Type | Award | Year Sort descending | Center(s) | Applications | Description |
|---|---|---|---|---|---|---|---|
Federal Laboratory Consortium (FLC) |
National Award | Excellence in Technology Transfer | Mast Cell Line for Research on Allergies and Inflammatory Diseases | 2009 | NIAID | Research Materials | Reactive mast cells are the culprit in allergic diseases and have also been implicated in other diseases ranging from autoimmune disorders to cancer to atherosclerosis. These immune sentinel cells normally defend against parasites and bacteria, but sometimes they overreact to harmless intruders,… |
Licensing Executives Society (LES) |
Industry-University-Government Interface Sector | Deals of Distinction™ Award | Development of Sodium Nitrite as a Repurposed Pharmaceutical Agent | 2009 | Therapeutics | “Intellectual property (IP) development and the licensing of IP is an essential component of innovation in our knowledge-based economy. Each year, major IP deals between companies help drive innovation and ensure that new products continue to reach businesses and consumers.” The National Institutes… | |
U.S. Department of Health and Human Services (HHS) |
Award | Green Champions Award | Green Team Efforts - NIH Office of Technology Transfer | 2009 | OD | The Office of Technology Transfer (OTT) implemented office-wide efforts in recycling, energy reduction and creating a paperless office. OTT procured recycling bins for paper, batteries, mail packages, printer toner, glass and plastic. When drafting documents, the office uses old paper and, when… | |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Excellence in Technology Transfer | Select100™ Multi-Specimen Loader and Image Acquisition System | 2008 | NCI | Software / Apps | Over the last 15 years, the application of computers to microscopes has significantly enhanced the level of automation that is possible once a specimen has been inserted into the microscope. A long-standing bottleneck has been the automated delivery of multiple specimens into an electron microscope… |
Biotechnology Industry Organization (BIO) |
Award | Innovation Corridor “Best Poster” Award | Novel Protein for Development of a Chlamydial Vaccine | 2007 | NIAID | Vaccines | BIO 2007 Innovation Corridor “Best Poster” AwardThe poster presented by Anna Z. Amar, Technology Development Associate, National Institute of Allergy and Infectious Diseases (NIAID), NIH – for a Novel Protein for Development of a Chlamydial Vaccine – was awarded “Best Poster” at the BIO 2007… |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Excellence in Technology Transfer | Targeted Treatments for Chronic and Painful Diseases | 2007 | NIDDK | Therapeutics | The researchers have developed a group of compounds useful in treating a wide variety of diseases, many of which are chronic and painful for those afflicted. These compounds, known as adenosine A3 receptor agonists, are small molecules that bind to adenosine A3 receptor and induce their biological… |
Federal Laboratory Consortium (FLC) |
National Award | Excellence in Technology Transfer | Gardasil™: A New Era in Cancer Prevention | 2007 | NCI | Vaccines | Human papilloma virus (HPV) is the most common sexually transmitted infection in the United States. The Centers for Disease Control and Prevention estimates that about 6.2 million Americans are infected with genital HPV each year and that over half of all sexually active men and women become… |
Federal Laboratory Consortium (FLC) |
National Award | Excellence in Technology Transfer | Kepivance®: Improving the Quality of Life for Cancer Patients | 2006 | NCI | Therapeutics | Cancer is the second largest cause of mortality in the U.S., but researchers have made tremendous progress in developing new and effective treatments to reduce these mortalities. The National Cancer Institute’s 2015 challenge goal is to turn cancer from a killer into a chronic disease in the next… |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Excellence in Technology Transfer | Accelerated Magnetic Resonance Imaging (T-SENSE) | 2005 | NHLBI | Diagnostics | This new, accelerated magnetic resonance imaging (MRI) method reduces the total imaging time for lengthy scans. The method may be used for imaging dynamic events such as heart motion or brain activity. The technology exploits the spatial and temporal correlation of magnetic resonance signals by… |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Excellence in Technology Transfer | Kepivance®: Improving the Quality of Life for Cancer Patients | 2005 | NCI | Therapeutics | Thus far the progress in our fight against cancer has come at a heavy price in the form of devastating side effects. While they are meant to kill cancer cells, most cancer drugs also destroy normal tissues. Mucositis (painful sores and ulcers in the lining of the mouth) is a common complication of… |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Excellence in Technology Transfer | Parvovirus B19 Diagnostic Test Kit | 2005 | NHLBI | Diagnostics | This development is the first and only FDA approved diagnostic test kit for parvovirus B19. Parvovirus B19 infection in pregnancy is often overlooked simply because most infected pregnant women are asymptomatic or have only mild manifestations, such as slight itching. However, pregnant women (in… |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Excellence in Technology Transfer | Taxus®Express2™: Bypassing By-pass Surgery with Paclitaxel-Coated Stents | 2005 | NIA | Medical Devices | Taxus® Express2™ has the potential to benefit many of the victims of cardiovascular disease, which causes 40% of all deaths in the US. After a heart attack, patients often undergo an invasive by-pass surgery or a less invasive angioplasty procedure to open up the clogged artery. In the latter… |
Federal Laboratory Consortium (FLC) |
National Award | Excellence in Technology Transfer | Excellence in Technology Transfer | 1999 | Non-Medical Devices | For the development of an indicator device to detect food quality.AwardeesFood and Drug Administration Dr. Jon G. Wilkes Dr. Dwight W. Miller | |
Federal Laboratory Consortium (FLC) |
National Award | Excellence in Technology Transfer | Excellence in Technology Transfer | 1997 | NHGRI | Therapeutics | For the development of gene therapy as a clinically useful procedure for training genetic diseases.AwardeeNational Human Genome Research Institute Dr. R. Michael Blaese |
Federal Laboratory Consortium (FLC) |
National Award | Excellence in Technology Transfer | Excellence in Technology Transfer | 1993 | NIA | Research Materials | In recognition of pioneering research and development and an unsurpassed commitment to transferring NIH/NIA technology to benefit mankind. AwardeeNational Institute on Aging Dr. Joseph Pitha |
Federal Laboratory Consortium (FLC) |
National Award | Excellence in Technology Transfer | Excellence in Technology Transfer | 1992 | NHLBI | Research Materials | In recognition of pioneering research and development that has brought NIH technology from the theoretical realms of the laboratory to clinical applications.AwardeeNational Heart Lung and Blood Institute Dr. W. French Anderson |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Excellence in Technology Transfer | Avelumab, New Therapy for Metastatic Merkel Cell and Urothelial Carcinomas | 2017 | NCI | Therapeutics | Through a CRADA with EMD Serono, NCI played an instrumental role in developing and expediting regulatory approval of EMD Serono’s checkpoint inhibitor, avelumab. Avelumab received FDA approval in 2017, only four years after EMD Serono and NCI added the study of avelumab to their… |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Excellence in Technology Transfer | Development of Large Scale Production, Anti-HIV Microbicide in Soya Beans | 2017 | NCI | HIV microbicides are not currently sold commercially, and many other HIV prevention techniques remain unavailable or unfeasible in developing countries where the disease is most prevalent. The technology transfer effort of developing large scale production methods of CV-N in soy beans helps to… | |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Rookie of the Year | Establishment of the First Federal Technology Transfer Ambassadors Program | 2017 | NCI | Drs. Alan Alfano, Laura Prestia, and Robert Sons, technology transfer rookies at the National Cancer Institute’s (NCI) Technology Transfer Center (TTC), established the first federal Technology Transfer Ambassadors Program (TTAP). The TTAP is a year-long, hybrid training/mentoring program for NCI… | |
Licensing Executives Society (LES) |
Award | Deals of Distinction™ Award | Zinbryta® for Treatment of Relapsing Multiple Sclerosis | 2017 | NINDS, NCI | Therapeutics | The 2017 Deals of Distinction™ Award was presented to National Institutes of Health, (NIH) along with its corporate partners, AbbVie and Biogen, for a license agreement related to the development and launch of Zinbryta® for treatment of relapsing multiple sclerosis (MS) The award, one of the… |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Educational Institution and Federal Laboratory Partnership | NCI Immunotherapy Fellowship Co-Sponsored by Society for Immunotherapy of Cancer | 2018 | NCI | NCI received the “Educational Institution and Federal Laboratory Partnership Award” at the Federal Laboratory Consortium 2018 Mid-Atlantic meeting for the establishment of the “NCI Immunotherapy Fellowship Co-sponsored by Society for Immunotherapy of Cancer.” “The award exemplifies what is possible… | |
Federal Laboratory Consortium (FLC) |
Mid-Atlantic Region Award | Representative of the Year | TTC Fellow Receives 2018 “Rookie Of The Year” Honors from the FLC MAR | 2018 | NCI | Sidra Ahsan, Ph.D., a fellow at the NCI TTC, received the “Rookie of the Year” award from the FLC MAR. The award recognizes the efforts of an FLC laboratory technology transfer professional who has demonstrated “outstanding work in the field of TT in a manner significantly over and above what was… | |
Licensing Executives Society (LES) |
Award | Deals of Distinction™ Award | Low-Cost, Temperature Tolerant Rotavirus Vaccine For Use in Developing Countries | 2018 | NIAID | Vaccines | Rotavirus is a disease that affects nearly every child worldwide. While most cases have mild symptoms, it is responsible for one third of infant hospitalizations for severe diarrhea and kills an estimated 200,000 children a year, mostly in developing countries. Researchers at the National Institute… |
United States Patent and Trademark Office (USPTO) |
Award | Patents for Humanity | Low-Cost, Temperature Tolerant Rotavirus Vaccine For Use in Developing Countries | 2018 | NIAID | Vaccines | Rotavirus is a disease that affects nearly every child worldwide. While most cases have mild symptoms, it is responsible for one third of infant hospitalizations for severe diarrhea and kills an estimated 200,000 children a year, mostly in developing countries. Researchers at the National Institute… |
Federal Laboratory Consortium (FLC) |
National Award | Excellence in Technology Transfer | Avelumab, New Therapy for Metastatic Merkel Cell and Urothelial Carcinomas | 2018 | NCI, NIAID | Therapeutics | Through a CRADA with EMD Serono, NCI played an instrumental role in developing and expediting regulatory approval of EMD Serono’s checkpoint inhibitor, avelumab. Avelumab received FDA approval in 2017, only four years after EMD Serono and NCI added the study of avelumab to their… |